How the UK Is Pioneering Stem Cell Research and Treatment for Pulmonary Hypertension
The UK is emerging as a leader in stem cell research and treatment for pulmonary hypertension (PH), a debilitating and often fatal condition. With advanced research facilities, innovative clinical trials, and a commitment to patient-centered care, the UK is paving the way for groundbreaking treatments that aim to improve the lives of PH patients.














